The Global Aromatase deficiency market was valued at USD 90.45 million in 2021 and is expected to reach USD 109.35 million by 2029, registering a CAGR of 2.40% during the forecast period of 2022 to 2029.
Aromatase Deficiency Market Dynamics
Drivers
- Rise in the number of cases of aromatase deficiency
Aromatase deficiency is a sexual development condition characterized by low estrogen levels and high testosterone leels. Because of excessive growth of long bones in the arms and legs, affected people are abnormally tall.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of aromatase deficiency market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the aromatase deficiency market growth.
Restraints/Challenges
On the other hand, high cost associated with the treatment as well as diagnosis will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the aromatase deficiency market. Additionally, lack of awareness among people and unfavourable healthcare policies will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.
Patient Epidemiology Analysis
Aromatase deficiency market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report.
Market Definition
Aromatase deficiency is an uncommon condition that affects the synthesis of estradiol, causing hirsutism in pregnant women, pseudohermaphroditism and virilization in women, and tall height, osteoporosis, and obesity in men. Female patients may be candidates for surgical genitalia modification depending on the degree of ambiguity, and ovarian cysts must be monitored. After puberty, daily estrogen treatment (0.625 mg/twice weekly increasing to daily) is required, which can be augmented with progesterone-like hormone and monthly gonadotrophin-releasing hormone antagonist therapies.
Global Aromatase Deficiency Market Scope
The aromatase deficiency market is segmented on the basis of diagnosis, treatment, route of administration, age of onset, end-users and distribution channel.
Diagnosis
- Physical Examination
- Gene Sequencing
- Genetic testing
- Others
Treatment
- Surgery
- Estrogen Replacement
- Others
Age of Onset
- Pediatrics
- Adults
- Geriatrics
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Get sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-aromatase-deficiency-market
Competitive Landscape and Aromatase Deficiency Market Share Analysis
Some of the major players operating in the aromatase deficiency market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (US)
- Sanofi (France)
- Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Abbott (US)
- Merck KGaA (Germany)
- Novo Nordisk A/S (Denmark)
- Genentech Inc. (US)
- Amgen Inc. (US)
- Endo International plc (Ireland)
Get toc report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-aromatase-deficiency-market
MAJOR TOC OF THE REPORT
Ø Chapter One: Introduction
Ø Chapter Two: Market Dynamics
Ø Chapter Three: Market Definition
Ø Chapter Four: Market Scope
Ø Chapter Five: Market Share Analysis
Get Full Details: https://www.databridgemarketresearch.com/reports/global-aromatase-deficiency-market
Browse Related Reports
Global Laboratory Information Systems (LIS) Market
Global Postoperative Management Market
Global Point-of-Care Testing (POCT) Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
